Skip to content

Clinical trial to evaluate effect of local application of Sharapunkha Malahar in the management of infected wound

Randomized controlled clinical trial to evaluate efficacy of local application of Sharapunkha malahar in the management of dushta vrana with special reference to infected wound - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074600
Enrollment
30
Registered
2024-10-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

None listed

Sponsors

Dr Raut Rohit Ashok
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of Dushta vrana 2. Wound size (30mm to 150 mm) 3. Wound of duration less than 1 year. 4. Diagnosed cases infected wound

Exclusion criteria

Exclusion criteria: 1. Anaemic patients having HB less than 8gm%. 2. Bleeding disorder. 3. Asthmatic patients, steroid dependent / immunocompromised. 4. HIV and any systemic / organic disease. 5. Vrana situated over asthi, sandhi, kostha, marma, adhishatana. 6. Diabetic wounds and varicose ulcers 7. Patient with malignancy

Design outcomes

Primary

MeasureTime frame
To reduce size of wound Timepoint: 7 days

Secondary

MeasureTime frame
1.To reduce size of wound 2.To decrease Slough 3.To decrease discharge 4.To decrease swelling 5.To decrease pain 6.To decrease smellTimepoint: 7 days

Countries

India

Contacts

Public ContactDr Rajendra H Amilkanthawar

Government Ayurved College and Hospital, Vajirabad, Nanded

drarajendrah@gmail.com9890569621

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026